Shimadzu Amyloid MS Service

For the rapid detection of Alzheimer’s Disease in blood

  • Shimadzu recently developed the Amyloid Mass Spectrometry (MS) Service — a new simple, low-cost blood test for early screening of amyloid-positive subjects. This method enables early and accurate detection of amyloid deposition in the brain with an easy-to-acquire blood sample.
    Unlike conventional methods, Shimadzu’s new test is minimally invasive, cost-effective and suitable for large-scale deployment.
    It’s the only blood test capable of detecting abnormal amyloid-beta deposition in the brain with 90% accuracy.
    For Research Use Only. Not For Use in Diagnostic Procedures. 

Shimadzu’s Amyloid MS Service offers…

Amyloid MS Service - Read our e-book
  • Reduced costs per test
  • A less invasive blood-based sampling technique
  • Low sample volume requirements (0.5 mL)
Shimadzu has built an efficient process for analyzing samples:
  1. Samples are collected and shipped to Shimadzu.
  2. Shimadzu analyzes the samples.
  3. Shimadzu sends a detailed report via electronic format.



For Research Use Only. Not for use in diagnostic procedures.

Top of This Page